Tissue-restricted control of established central nervous system autoimmunity by TNF receptor 2–expressing Treg cells - CRCL-Régulation moléculaire et immunité des cancers
Article Dans Une Revue Proceedings of the National Academy of Sciences of the United States of America Année : 2021

Tissue-restricted control of established central nervous system autoimmunity by TNF receptor 2–expressing Treg cells

Cédric Auffray
  • Fonction : Auteur
Bruno Lucas
  • Fonction : Auteur

Résumé

CD4+Foxp3+ regulatory T (Treg) cells are central modulators of autoimmune diseases. However, the timing and location of Treg cell-mediated suppression of tissue-specific autoimmunity remain undefined. Here, we addressed these questions by investigating the role of tumor necrosis factor (TNF) receptor 2 (TNFR2) signaling in Treg cells during experimental autoimmune encephalomyelitis (EAE), a model of multiple sclerosis. We found that TNFR2-expressing Treg cells were critical to suppress EAE at peak disease in the central nervous system but had no impact on T cell priming in lymphoid tissues at disease onset. Mechanistically, TNFR2 signaling maintained functional Treg cells with sustained expression of CTLA-4 and Blimp-1, allowing active suppression of pathogenic T cells in the inflamed central nervous system. This late effect of Treg cells was further confirmed by treating mice with TNF and TNFR2 agonists and antagonists. Our findings show that endogenous Treg cells specifically suppress an autoimmune disease by acting in the target tissue during overt inflammation. Moreover, they bring a mechanistic insight to some of the adverse effects of anti-TNF therapy in patients.
Fichier principal
Vignette du fichier
Ronin et al. - 2021 - Tissue-restricted control of established central n.pdf (8.14 Mo) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03185017 , version 1 (30-03-2021)

Identifiants

Citer

Emilie Ronin, Charlotte Pouchy, Maryam Khosravi, Morgane Hilaire, Sylvie Grégoire, et al.. Tissue-restricted control of established central nervous system autoimmunity by TNF receptor 2–expressing Treg cells. Proceedings of the National Academy of Sciences of the United States of America, 2021, 118 (13), pp.e2014043118. ⟨10.1073/pnas.2014043118⟩. ⟨hal-03185017⟩
148 Consultations
177 Téléchargements

Altmetric

Partager

More